Invasive fungal sinusitis in patients undergoing bone marrow transplantation.

P Drakos(Hadassah Academic College), S Slavin(N. I. Lobachevsky State University of Nizhny Novgorod), Reuven Or(Hadassah Academic College), Galia Rahav(Unknown), D. Ne'emean(Hadassah Medical Center), Arnon Nagler(Sheba Medical Center), E Naparstek(Hadassah Academic College), Dan Engelhard(Hadassah Academic College), Joseph Kapelushnik(Hadassah Medical Center)

PubMed

September 1, 1993

Cited by 163

Related Papers

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

|Blood|1998|1.9k

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

|Blood|1998|1.8k

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

|New England Journal of Medicine|2020|859

Gain-of-function human <i>STAT1</i> mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis

|The Journal of Experimental Medicine|2011|797

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

|Journal of Clinical Oncology|2013|439